InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
7
T+90 hit rate
0%
T+90 mean return
-14.7%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Tupper Colleen, Chief Financial Officer. Director active across 2 companies, notably Collegium Pharmaceutical, INC. In total, 14 disclosures have been published. Breakdown: 0 buy · 7 sells. Total volume traded: €1.8m. History available since 24 May 2021. The latest transaction was filed on 20 March 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations14 total
1,206 shares@ US$30.00111.8% of flowCommon StockSEC:0001062993-25-006149:0
977 shares@ US$30.00341.5% of flowCommon StockSEC:0001062993-25-005753:0
10,445 shares@ US$30.00616.0% of flowCommon StockSEC:0001062993-25-005395:0
1,949 shares@ US$30.003.0% of flowCommon StockSEC:0001062993-25-005021:0
51,768 shares0Common StockSEC:0001062993-25-002178:0
19,710 shares@ US$34.214534.5% of flowCommon StockSEC:0001062993-24-011413:0
40,600 shares0Common StockSEC:0001062993-24-003170:0
31,640 shares@ US$23.772638.9% of flowCommon StockSEC:0001062993-23-007174:0
45,045 shares0Common StockSEC:0001062993-23-003477:0
4,350 shares@ US$17.354.2% of flowCommon StockSEC:0001062993-22-020614:0
52,500 shares0Common StockSEC:0001062993-22-006643:0
45,500 shares0Common StockSEC:0001062993-22-004322:0
42,000 shares0Common StockSEC:0001192482-21-000452
42,000 shares0Common StockSEC:0001192482-21-000452:0
14 of 14 declarations
About Tupper Colleen
Colleen Tupper is the Chief Financial Officer and Executive Vice President of COLLEGIUM PHARMACEUTICAL, INC. She is responsible for the financial management of the company, including budgeting and financial performance analysis. Her expertise is crucial for the strategic development of the organization.
